Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
Serum SP-D concentration is an important biomarker in patients with idiopathic pulmonary fibrosis, but its role in lung fibrosis is unknown. We examined the role of SP-D in bleomycin (BLM) induced pulmonary fibrosis model using SP-D conditional mice. BLM-treated SP-D off mice had increased lung fibrois compared to SP-D on mice. SP-D deficiency also increased macrophage and fibrocyte-dominant cell infiltration and the expression of growth factors (TGF-beta, PDGF) from the cells in the lung of BLM treated mice. These data suggest that alveolar SP-D regulates numbers of macrophages and fibrocytes in the lungs, growth factor expression, and fibrotic lung remodeling in response to BLM injury
|